In a significant step toward combating Thalassemia, Health 1 Hospital in Ahmedabad recently hosted a transformative HLA testing and counseling session for 20 families of Thalassemia patients. Organized by Sankalp India Foundation, the event aimed to educate families about Thalassemia and the life-changing potential of Bone Marrow Transplantation (BMT).
In a significant acknowledgment of Sankalp India Foundation's tireless efforts in healthcare, Mr. Jayesh Rathod, the Epidemic Medical Officer of Wadhwan, praised the organization's comprehensive approach to public health during a recent meeting at the Taluk Health Office. "Sankalp India Foundation is doing the job that we're supposed to do," remarked Mr. Rathod, followed by enthusiastic applause from the gathered officials.
On 6th January, Sankalp India Foundation marked a significant milestone in its mission to streamline thalassemia care by initiating critical improvements at the newly established government day care center in Ananthpur. This center, which had long struggled with inadequate facilities and inefficient processes, is now poised to offer faster and more reliable treatment, thanks to Sankalp’s dedicated efforts.
Sankalp India Foundation is excited to announce the successful installation of a state-of-the-art blood irradiator at our facility, marking a significant advancement in the safety and effectiveness of bone marrow transplants (BMT). This essential piece of equipment will play a pivotal role in ensuring the highest standards of care for our patients undergoing transplants by irradiating blood products before they are used in treatment.
We started the year strong! On the Cure side, we’re focused on keeping our program fully engaged throughout the year and planning the inauguration of our new unit in Ahmedabad.
Within Management, we’re restructuring to handle increased activity, addressing current challenges, and creating a mitigation plan.
On the Prevention front, we’ve tested over 15,000+ individuals in the first month, with plans to expand further.
